MRI The Appy | Tazo or Cefepime episode artwork

EPISODE · Nov 4, 2023 · 7 MIN

MRI The Appy | Tazo or Cefepime

from JournalFeed

The JournalFeed podcast for the week of Oct 30 Nov 3, 2023.These are summaries from just 2 of the 5 article we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.Tuesday Spoon Feed:After a non-diagnostic screening ultrasound for appendicitis, a rapid-MRI has high clinical accuracy in establishing the appropriate diagnosis (appendicitis or not) in a pediatric patient population.Friday Spoon Feed:In this randomized control trial (RCT) of patients receiving cefepime or piperacillin-tazobactam, there was no difference in risk of acute kidney injury (AKI) between the two groups. However, those who received cefepime were more likely to have neurologic side effects.

Episode metadata supplied by the publisher feed · Published Nov 4, 2023

Embed this episode

NOW PLAYING

MRI The Appy | Tazo or Cefepime

0:00 7:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JournalFeed?

This episode is 7 minutes long.

When was this JournalFeed episode published?

This episode was published on November 4, 2023.

Can I download this JournalFeed episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!